Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1534-6293

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives ; volume:18 ; number:5 ; day:3 ; month:4 ; year:2018 ; pages:1-11 ; date:5.2018
Current neurology and neuroscience reports ; 18, Heft 5 (3.4.2018), 1-11, 5.2018

Creator: Park, Jin-Sung

Contributor: Davis, Ryan L.
Sue, Carolyn M.
SpringerLink (Online service)

DOI: 10.1007/s11910-018-0829-3

URN: urn:nbn:de:101:1-2018062810002947821867

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Park, Jin-Sung
Davis, Ryan L.
Sue, Carolyn M.
SpringerLink (Online service)

Other Objects (12)

Mitochondrial dysfunction in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Therapeutic drug monitoring in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Therapeutic drug monitoring in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Therapeutic drug monitoring in Parkinson’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Mitochondrial dysfunction in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Therapeutic drug monitoring in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Therapeutic drug monitoring in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Therapeutic drug monitoring in Parkinson’s disease

Related objects

Reset password